Ms In Hwa Um
data source: symbiosis
Research Overview from research@st-andrews
Recent publications listed in research@st-andrews
Koussounadis, A, Langdon, S, Um, IH, Kay, C, Francis, K, Harrison, DJ & Smith, VA 2016, 'Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models' BMC Cancer, vol. 16, 205. https://doi.org/10.1186/s12885-016-2212-6
Briffa, R, Um, IH, Faratian, D, Zhou, Y, Turnbull, AK, Langdon, SP & Harrison, DJ 2015, 'Multi-scale genomic, transcriptomic and proteomic analysis of colorectal cancer cell lines to identify novel biomarkers' PLoS One, vol. 10, no. 12, e0144708. https://doi.org/10.1371/journal.pone.0144708
Huang, R, Langdon, SP, Tse, M, Mullen, P, Um, IH, Faratian, D & Harrison, DJ 2015, 'The role of HDAC2 in chromatin remodelling and response to chemotherapy in ovarian cancer' Oncotarget, vol. 7, no. 4, pp. 4695-4711. https://doi.org/10.18632/oncotarget.6618
Koussounadis, A, Langdon, S, Um, IH, Harrison, DJ & Smith, VA 2015, 'Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system' Scientific Reports, vol. 5, 10775. https://doi.org/10.1038/srep10775
Ward, C, Meehan, J, Mullen, P, Supuran, C, Dixon, JM, Thomas, JS, Winum, J-Y, Lambin, P, Dubois, L, Pavathaneni, N-K, Jarman, EJ, Renshaw, L, Um, IH, Kay, C, Harrison, DJ, Kunkler, IH & Langdon, SP 2015, 'Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models' Oncotarget, vol. 6, no. 28, pp. 24865-24870.
Francis, KE, Mullen, P, Um, I, Kay, C, Harrison, DJ & Langdon, SP 2013, 'Characterisation of phosphorylated checkpoint kinase 1 as a poor prognostic biomarker in serous ovarian cancer' Journal of Pathology, vol. 231, pp. 46.
Langdon, S, Faratian, D, Gourley, C, Harrison, D, Um, IH & Smyth, J 2009, The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors: Aromatase inhibitors: Types, Mode of Action and Indications. in Aromatase inhibitors: Types, Mode of Action and Indications. Cancer Etiology, Diagnosis and Treatment Series, Nova Science Pub Incorporated, pp. 163-174.